BioElectronics Corporation Announces Distribution Agreement With Molecular Ionics, LLC

FREDERICK, Md., Jan. 9 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that Molecular Ionics, LLC (formerly Protective Medical Products) has signed a Distribution Agreement and placed their first order.

Molecular Ionics, LLC, with offices at 8946 Old Pasco Road, Wesley Chapel, Florida, will handle the distribution of ActiPatch Therapy Products to medical professionals in the northwest counties of Florida. Molecular Ionics is a focused company providing wound care products and services. Their staff has a total of 116 years of experience in the medical industry as either a provider of products and services or in clinical care. “We are pleased to have Molecular Ionics join with us to bring ActiPatch Therapy products to the Florida medical community and look to have strong sales results as a result of our association,” said Andrew Whelan, President of BioElectronics Corporation.

“Molecular Ionics, LLC specializes in electro-chemical wound care products. We are therefore pleased to offer our clients the innovative, drug- free ActiPatch products,” said Tom McCarthy, Managing Director of Molecular Ionics, LLC.

For more information on Molecular Ionics, LLC visit http://www.promedpro.com

ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

BioElectronics Corporation

CONTACT: Lawrence H. Rosen, CFO, or Andrew J. Whelan, President & CEO,both of BioElectronics Corporation, +1-301-644-3906, Fax: +1-301-644-3937,info@bioelectronicscorp.com

MORE ON THIS TOPIC